Develop business strategies Of Prostate Cancer Market Analysis and Global Drug Forecast 2026

"The Latest Research Report PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2026 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

The prostate cancer market is expected to experience a moderate growth between 2016 and 2026. The main drivers of growth will be the expected label expansion of second-generation hormonal agents into hormone-sensitive disease and non-metastatic castration resistant prostate cancer (nmCRPC), and the launch and uptake of nine new premium-priced therapies.

Until now, the hormone sensitive setting has been dominated by the use of cheap first-generation hormonal agents, with the use of premium-priced second-generation hormonal agents (Xtandi and Zytiga) limited to metastatic CRPC. The prostate cancer competitive landscape is going to experience a substantial change. Given that Zytiga and Xtandi are limited by the insurgence of acquired resistance, physicians will face the critical issue of determining the best treatment sequence for subsequent lines of therapy, most notably in the mCRPC setting. Additionally, companies are now moving toward a more personalized approach in prostate cancer, targeting mCRPC patients with specific genetic signatures, such as PTEN loss and DNA repair abnormalities. GlobalData expects these biomarker-driven drug development strategies to induce further patient stratification and to add complexity to the CRPC treatment algorithm.

Get Sample Copy of this report @ https://www.marketresearchreports.biz/sample/sample/1607657

Scope

- Overview of prostate cancer, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and disease management.
- Annualized prostate cancer therapeutics market revenue, cost of therapy per patient, and treatment usage patterns in seven patient segments, forecast from 2016 to 2026.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the prostate cancer therapeutics market.
- Pipeline analysis: comprehensive data assessing emerging trends and mechanisms of action under development for prostate cancer. The most promising candidates in Phase III development are profiled.
- Analysis of the current and future market competition in the global prostate cancer market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global prostate cancer market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global prostate cancer market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Browse Complete Report with TOC @ https://www.marketresearchreports.biz/reports/1607657/pharmapoint-prostate-cancer-global-market-research-reports/toc

Table of Contents

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Prostate Cancer: Executive Summary 13
2.1 Value of Prostate Cancer Market to Increase Two-Fold By 2026 14
2.2 Xtandi to Become the Undisputed Leader in the Global Prostate Cancer Market 16
2.3 Prostate Cancer Treatment Landscape to Undergo Dramatic Change 18
2.4 Prostate Cancer Pipeline Moving Towards Precision Medicine 18
2.5 Unmet Need Will Remain for the Identification of New Targets and Biomarkers of Response 20
2.6 What Do the Physicians Think? 20
3 Introduction 23
3.1 Catalyst 23
3.2 Related Reports 24
3.3 Upcoming Related Reports 24
4 Disease Overview 25
4.1 Etiology and Pathophysiology 25
4.1.1 Etiology 25
4.1.2 Pathophysiology 26
4.1.3 Biomarkers 27
4.2 Classification or Staging Systems 29
4.3 Symptoms 31
4.4 Prognosis 31
4.5 Quality of Life 31

View Sample PDF @
https://www.marketresearchreports.biz/reports/1607657/pharmapoint-prostate-cancer-global-market-research-reports.pdf

5 Epidemiology 33
5.1 Disease Background 33
5.2 Risk Factors and Comorbidities 33
5.3 Global and Historical Trends 35
5.3.1 US 36
5.3.2 5EU 37
5.3.3 Japan 37
5.4 Forecast Methodology 37
5.4.1 Sources Used 38
5.4.2 Forecast Assumptions and Methods 43
5.5 Epidemiological Forecast for Prostate Cancer (2016-2026) 52
5.5.1 Diagnosed Incident Cases of Prostate Cancer 52
5.5.2 Age-Specific Incident Cases of Prostate Cancer 53
5.5.3 Incident Cases by Stage at Diagnosis 54
5.5.4 Incident Cases by Risk of Biochemical Recurrence 55
5.5.5 10-Year Diagnosed Prevalent Cases of Prostate Cancer 56
5.5.6 10-Year Prevalent CRPC Cases 57
5.5.7 10-Year Prevalent Metastatic Prostate Cancer Cases 58
5.5.8 10-Year Prevalent mCRPC Cases with HRD Mutations 59
5.6 Discussion 60
5.6.1 Epidemiological Forecast Insight 60
5.6.2 Limitations of Analysis 62
5.6.3 Strengths of Analysis 62
6 Disease Management 63
6.1 Diagnosis Overview 63
6.2 Treatment Overview 66
6.2.1 Treatment Guidelines and Leading Prescribed Drugs 66
6.2.2 Clinical Practice 67
6.3 US 90
6.3.1 Diagnosis 90
6.3.2 Clinical Practice 92
6.4 France 94
6.4.1 Diagnosis 95
6.4.2 Clinical Practice 95
6.5 Germany 98
6.5.1 Diagnosis 98
6.5.2 Clinical Practice 99
6.6 Italy 102
6.6.1 Diagnosis 102
6.6.2 Clinical Practice 103
6.7 Spain 105
6.7.1 Diagnosis 105
6.7.2 Clinical Practice 105
6.8 UK 107
6.8.1 Screening and Diagnosis 107
6.8.2 Clinical Practice 108
6.9 Japan 111
6.9.1 Diagnosis 111
6.9.2 Clinical Practice 112

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

This release was published on openPR.